Dupixent
Dupixent Fails to Win FDA Approval for Hives Disorder, Needs More Data
Anika Sharma
Regeneron and Sanofi have faced an unexpected hurdle in their pursuit of regulatory approval for Dupixent, a monoclonal antibody aimed ...
How Skyrizi Outspent Other Drugs in a Tough Market
SG Tylor
In July, AbbVie’s Skyrizi maintained its position as the top pharma drug ad spender for the second consecutive month, but ...
Sanofi Reports ‘Solid’ Q2 Performance with 3 Ongoing Launches and Dupixent Nearing €10B Milestone
SG Tylor
Sanofi, a leading pharmaceutical company, is navigating the challenges posed by the entry of generic versions of its drug Aubagio ...
